Comparison

ASN Highlights vs KAK

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

ASN Highlights

Features
Read full description

This ASN Highlights 2020, Event App provides you all the information you need about the ASN Highlights 2020 program. You can access • Program Information • Browse, faculty profile & talks summaries • Browse program schedule • Ask a question to the faculty • Post your program feedback • Access faculty slides

About

KAK

Features
Read full description

Quick risk-calculator for contrast-induced nephropathy based on validated clinical model KAK-CIN Score is a clinical decision-support tool designed to help healthcare professionals estimate the probability of Contrast-Induced Nephropathy (CIN) in patients who will receive intravascular contrast medium. The algorithm is based on the peer-reviewed study by Kulkarni et al (Indian Journal of Nephrology, 2023) which derived and validated a simplified risk score system. Key features: Input four key patient variables: Estimated Glomerular Filtration Rate (eGFR) Contrast volume (mL) Route of contrast administration (arterial vs intravenous) Presence or absence of Diabetes Mellitus Instantly calculates a risk-percentage for CIN and provides a risk category (e.g., low, moderate, high) and provides the CIN Score. Published Journal: https://indianjnephrol.org/?view-pdf=1&embedded=true&article=af81b65b1e790875fb17d4a368ca9457Aplh7GbponE%3D Why use KAK-CIN Score? The original study included 1,300 patients (derivation 1,000 + validation 300) with an observed incidence of CIN of 3.8 %. The model showed high sensitivity (90.4 %) and specificity (98.8 %) in the validation cohort. Unlike many prior CIN risk models that were limited to cardiac catheterisation, this score covers both intra-arterial and intravenous contrast exposure. Important disclaimer This app is for educational and decision-support purposes only. It does not replace clinical judgement, institutional protocols or specialist consultation. Use results in conjunction with the full clinical context. The authors are not responsible for any clinical outcomes resulting from use of this tool. Always follow local guidelines. Privacy & Security No patient-identifiable data is stored beyond your device.

Screenshots

ASN Highlights2 screens
KAK4 screens

Verdict

The call

The clearest difference is update cadence: KAK at fortnightly against ASN Highlights's every 3 months. ASN Highlights's advantage is iOS requirement (9.2 vs 13.0). On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

ASN Highlights ships an update every 3 months, KAK fortnightly. The most recent releases landed on October 26, 2026 and November 9, 2026 respectively.

Scorecard2 real differences · 4 level
ASN Highlights versus KAK: the parameters behind the verdict, then further details
ParameterASN HighlightsKAK
PriceFreeFree
Update frequencyEvery 3 monthsFortnightly — better
AdsNoNo
In-app purchasesNoNo
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS9.2 — better13.0
Further details — not scored
Size62 MB20 MB
Age rating4+4+
DeveloperUpdate Video Publication Pvt. Limited ( Mediquest Group, India)Mehulkumar Thakkar

In-app purchases

None

ASN Highlights

No in-app purchases

None

KAK

No in-app purchases

Questions

Is ASN Highlights free?
ASN Highlights is free to download, with no in-app purchases.
Is KAK free?
KAK is free to download, with no in-app purchases.
Do ASN Highlights or KAK have ads?
Neither ASN Highlights nor KAK shows ads.
Which is updated more often, ASN Highlights or KAK?
ASN Highlights ships an update every 3 months, and KAK fortnightly. Most recently, ASN Highlights was updated on October 26, 2026 and KAK on November 9, 2026.

Other comparisons